Skip to main content
. 2026 May 22;13(6):596. doi: 10.3390/bioengineering13060596
PCa Prostate Cancer
SBRT Stereotactic Body Radiation Therapy
CK CyberKnife
MLC Multileaf Collimator
IRIS Iris Variable Aperture Collimator
ASR Age-Standardized Rate
PSA Prostate-Specific Antigen
TCP Tumor Control Probability
OAR Organ At Risk
PTV Planning Target Volume
MU Monitor Units
IGRT Image-Guided Radiation Therapy
ADT Androgen Deprivation Therapy
CT Computed Tomography
CTV Clinical Target Volume
GTV Gross Tumor Volume
CI Conformity Index
nCI new Conformity Index
HI Homogeneity Index
GI Gradient Index
PIV Prescription Isodose Volume
TIV Tumor Isodose Volume